Kiniksa Pharmaceuticals is a biopharmaceutical company that seeks to develop and market therapeutic medicines for patients who suffer from severe, unmet medical conditions globally. The company has several product candidates in its pipeline, including ARCALYST, Mavrilimumab, Vixarelimab, and KPL-404, which are in different clinical trial phases. The company was founded in 2015 and is headquartered in Hamilton, Bermuda.
Address:105 Piccadilly, London, United Kingdom, W1J 7NJ
About
Kiniksa Pharmaceuticals is a biopharmaceutical company that seeks to develop and market therapeutic medicines for patients who suffer from severe, unmet medical conditions globally. The company has several product candidates in its pipeline, including ARCALYST, Mavrilimumab, Vixarelimab, and KPL-404, which are in different clinical trial phases. The company was founded in 2015 and is headquartered in Hamilton, Bermuda.